The company recently released an RUO RNA extraction kit, and plans to launch a liquid biopsy pan-cancer test and disease-specific NGS panels later this year.
A 400-sample retrospective analysis in invasive breast cancer will inform a basket trial that the Ontario Institute for Cancer Research hopes to soon launch.
Harvard researchers found that variants previously classified as pathogenic were in fact benign, disproportionately affecting patients of African ancestry.
The technique will use optical maps and barcodes in order to generate long scaffolds from short-read sequencing technology.
The Sydney-based genomics center is implementing diagnostic sequencing pipelines and figuring out best practices for incorporating genomics into healthcare.
In PLOS this week: genetic factors associated with facial features, a new mutation that makes individuals more prone to Brugada syndrome, and more.
Nutrigenomic companies offer gene-based diet advice, the Wall Street Journal reports.
Researchers have found a new kind of virus — one that starts out broken up into five parts.
Nature News explores the president's "science legacy."